Health | The Financial Express

Health

AstraZeneca says its vaccine should be effective against new coronavirus variant

British drugmaker AstraZeneca Plc told Reuters on Tuesday its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were underway to fully probe the impact of the mutation. "AZD1222 (AstraZeneca's vaccine candidate) contains the genetic material...

New COVID-19 variants: What we know so far, in 500 words

Three new variants of COVID-19 have been detected in recent...

Production and delivery challenges beset the 2021 year of the vaccine

As 2020 closes, regulatory approval of Covid-19 vaccines has raised...

WHO calls meeting on new virus variant, European chief says

The World Health Organization (WHO) will convene a meeting of...

New coronavirus variant may infect children more easily: Scientists

A new variant of the coronavirus spreading rapidly in Britain...

WHO advises against major alarm over new coronavirus strain

The World Health Organization cautioned against major alarm over a...

New coronavirus variant: What do we know?

The rapid spread of a new variant of coronavirus in...

COVAX alliance doubles global vaccine supply deals to 2.0b doses

The COVAX alliance, which aims to secure COVID-19 vaccines for...

Study finds babies born to COVID-19 mothers have antibodies

All five babies born to women with COVID-19 infection during...

US FDA advisory panel sets stage for Moderna vaccine authorisation

A panel of outside advisers to the US Food and...

EU to start Covid-19 vaccination on December 27

The European Union (EU) will start vaccination for coronavirus (Covid-19)...

Poorer nations may not get Covid shots until 2024 as WHO vaccine scheme risks failure

The global scheme to deliver coronavirus (Covid-19) vaccines to poorer...

EU could give final consent for Pfizer COVID-19 vaccine on Dec 23

The European Union could give final approval for the Pfizer-BioNTech...

One in four people globally may not get vaccines until 2022

Nearly one in four people may not get Covid-19 vaccines...

Poorer countries face long wait for vaccines despite promises

With Americans, Britons and Canadians rolling up their sleeves to...

IFRC hands over four ambulances, sample collection van to BDRCS

The International Federation of Red Cross and Red Crescent Societies...

Five key genes linked to severe Covid19 found

Five key genes are linked with the most severe form...

Sanofi, GSK delay COVID-19 vaccine, marking setback for global fight

Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine...

AstraZeneca to test combination of its vaccine with Sputnik

AstraZeneca will start clinical trials to test a combination of...

Novartis gets EU approval for cholesterol drug Leqvio

Novartis has received approval from the European Commission for Leqvio,...

Psoriasis: More than a skin disease

Gates Foundation pledges additional $250m to deliver coronavirus vaccines

Patients found reluctant to undergo rapid Covid-19 tests

People with serious allergies asked to avoid Pfizer vaccine

Rich countries acquire 53pc vaccine doses, global coalition says

Poorer nations left behind as rich ones hoard Covid-19 vaccines

US institute offers Bangladesh assistance to set vaccine priority

The US health regulatory and research institute CDC has said it was willing to offer Bangladesh its expertise in fixing priority of potential anti-Covid-19 vaccine recipients, fearing the issue to emerge as a “major challenge” in coming days. “We can help (Bangladesh) in different ways … if necessary we can...

Clinical trial of Ivermectin shows promise against Covid-19

Study finds women more susceptible to heart diseases than men

WHO targets distribution of 500m vaccine doses by COVAX in Q1 2021

? 2020 - All Rights with The Financial Express